Related Experiment Video
Updated: Jun 12, 2026

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
Published on: December 29, 2015
JC virus small T antigen binds phosphatase PP2A and Rb family proteins and is required for efficient viral DNA
Brigitte Bollag1, Catherine A Hofstetter, Marta M Reviriego-Mendoza
1Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, Pennsylvania, United States of America.
Background:
The human polyomavirus, JC virus (JCV) produces five tumor proteins encoded by transcripts alternatively spliced from one precursor messenger RNA. Significant attention has been given to replication and transforming activities of JCV's large tumor antigen (TAg) and three T' proteins, but little is known about small tumor antigen (tAg) functions. Amino-terminal sequences of tAg overlap with those of the other tumor proteins, but the carboxy half of tAg is unique. These latter sequences are the least conserved among the early coding regions of primate polyomaviruses.
Methodology And Findings:
We investigated the ability of wild type and mutant forms of JCV tAg to interact with cellular proteins involved in regulating cell proliferation and survival. The JCV P99A tAg is mutated at a conserved proline, which in the SV40 tAg is required for efficient interaction with protein phosphatase 2A (PP2A), and the C157A mutant tAg is altered at one of two newly recognized LxCxE motifs. Relative to wild type and C157A tAgs, P99A tAg interacts inefficiently with PP2A in vivo. Unlike SV40 tAg, JCV tAg binds to the Rb family of tumor suppressor proteins. Viral DNAs expressing mutant t proteins replicated less efficiently than did the intact JCV genome. A JCV construct incapable of expressing tAg was replication-incompetent, a defect not complemented in trans using a tAg-expressing vector.
Conclusions:
JCV tAg possesses unique properties among the polyomavirus small t proteins. It contributes significantly to viral DNA replication in vivo; a tAg null mutant failed to display detectable DNA replication activity, and a tAg substitution mutant, reduced in PP2A binding, was replication-defective. Our observation that JCV tAg binds Rb proteins, indicates all five JCV tumor proteins have the potential to influence cell cycle progression in infected and transformed cells. It remains unclear how these proteins coordinate their unique and overlapping functions.
Insights
JC virus (JCV) small tumor antigen (tAg) is crucial for viral DNA replication and interacts with cellular proteins like PP2A and Rb. JCV tAg has unique functions among polyomaviruses, impacting cell cycle progression.
Area of Science:
- Virology
- Molecular Biology
- Oncology
Background:
- JC virus (JCV) encodes five tumor proteins, with limited understanding of the small tumor antigen (tAg).
- tAg's unique carboxy-terminal sequences are less conserved across primate polyomaviruses.
- tAg's functions are less studied compared to JCV's large TAg and T' proteins.
Purpose of the Study:
- To investigate the interaction of JCV tAg with cellular proteins regulating cell proliferation and survival.
- To determine the role of JCV tAg in viral DNA replication.
- To compare JCV tAg's properties with other polyomavirus small t antigens.
Main Methods:
- Utilized wild-type and mutant forms of JCV tAg (P99A, C157A) to study protein interactions.
- Assessed interactions with protein phosphatase 2A (PP2A) and Rb family proteins in vivo.
- Evaluated viral DNA replication efficiency of JCV constructs with altered or absent tAg.
Main Results:
- JCV tAg binds to the Rb family of tumor suppressor proteins, unlike SV40 tAg.
- The P99A tAg mutant showed inefficient interaction with PP2A.
- tAg-null and replication-defective tAg mutants exhibited significantly reduced viral DNA replication.
Conclusions:
- JCV tAg plays a significant role in viral DNA replication in vivo.
- JCV tAg's interaction with PP2A and Rb proteins influences cell cycle progression.
- JCV tAg possesses unique properties and contributes to the oncogenic potential of JCV.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
DNA Bacteriophages
Retrovirus Life Cycles
Mechanisms of Retrovirus-induced Cancers

